代谢综合征与认知障碍之间的关联:分析观察性研究的元分析
Mobin Azami1, Maryam Afraie2, Pardis Mohammadzadeh2
1Kurdistan University of Medical Sciences, Sanandaj, Iran.
Cognitive neuropsychiatry
|May 20, 2025
概括
代谢综合征 (MetS) 显著增加了认知障碍的风险. 早期查和量身定制的公共卫生策略对于减轻这种风险至关重要,特别是在多样化的人口中.
科学领域:
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 代谢综合征 (MetS) 和认知衰退之间的关系尚未完全理解.
- 现有的研究对MetS与痴呆症或认知障碍之间的关联提出了相互矛盾的证据.
研究的目的:
- 进行全面的文献综述和元分析.
- 评估MetS与认知能力下降风险之间的关联.
主要方法:
- 在主要数据库 (Medline,科学网,Scopus,Embase) 进行系统的文献搜索,直到2023年1月.
- 包括队列和病例控制研究.
- 使用STATA版本17的元分析.
主要成果:
- 对20项研究 (5,727,594名参与者) 的综合分析显示,MetS与认知障碍之间存在显著的关联 (RR=1.34,95% CI:1.25-1.43).
- 与其他方法相比,NCEP-ATP III诊断标准显示出更强的关联.
- 亚洲人群的风险最高,其次是欧洲和美国人群.
结论:
- 代谢综合征与认知障碍的风险增加有显著联系.
- 诊断标准和生活方式因素的地理差异可能会影响观察到的关联.
- 强调需要早期查和特定区域的干预措施,以防止MetS患者的认知能力下降.
相关概念视频
Negative and Cognitive Symptoms of Schizophrenia
39
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
39
Cognitive Development During Adulthood
38
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
38
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
87
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
87
Alzheimer's Disease: Overview
405
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
405
What is Metabolism?
112.8K
Overview
112.8K


